Galabiosylceramide is present in human cerebrospinal fluid

Hisako Akiyama, Mitsuko Ide, Toshiyuki Yamaji, Yasuaki Mizutani, Yoshiki Niimi, Tatsuro Mutoh, Hiroyuki Kamiguchi, Yoshio Hirabayashi

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Cerebrospinal fluid (CSF) contains glycosphingolipids, including lactosylceramide (LacCer, Galβ(1,4)Glcβ-ceramide). LacCer and its structural isomer, galabiosylceramide (Gb2, Galα(1,4)Galβ-ceramide), are classified as ceramide dihexosides (CDH). Gb2 is degraded by α-galactosidase A (GLA) in lysosomes, and genetic GLA deficiency causes Fabry disease, an X-linked lysosomal storage disorder. In patients with Fabry disease, Gb2 accumulates in organs throughout the body. While Gb2 has been reported to be in the liver, kidney, and urine of healthy individuals, its presence in CSF has not been reported, either in patients with Fabry disease or healthy controls. Here, we isolated CDH fractions from CSF of patients with idiopathic normal pressure hydrocephalus. Purified CDH fractions showed positive reaction with Shiga toxin, which specifically binds to the Galα(1,4)Galβ structure. The isolated CDH fractions were analyzed by hydrophilic interaction chromatography (HILIC)-electrospray ionization tandem mass spectrometry (ESI-MS/MS). HILIC-ESI-MS/MS separated LacCer and Gb2 and revealed the presence of Gb2 and LacCer in the fractions. We also found Gb2 in CSF from neurologically normal control subjects. This is the first report to show Gb2 exists in human CSF.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalBiochemical and Biophysical Research Communications
Publication statusPublished - 15-01-2021

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Galabiosylceramide is present in human cerebrospinal fluid'. Together they form a unique fingerprint.

Cite this